Wound Care (Pharmacies) - United States

United States

Highlights

Revenue in the Wound Care market is projected to reach US$1.04bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.46%, resulting in a market volume of US$1.07bn by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$3.05 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Wound Care (Pharmacies) market in United States is experiencing significant growth due to several factors.

Customer preferences: Customers in the United States have a strong preference for convenience and accessibility when it comes to healthcare products. They value the ability to easily purchase wound care products from their local pharmacies, as it allows them to quickly address their healthcare needs. Additionally, customers in the United States are increasingly seeking out products that are effective, affordable, and of high quality. They are willing to invest in wound care products that provide optimal healing and minimize the risk of infection.

Trends in the market: One of the key trends in the Wound Care (Pharmacies) market in United States is the increasing demand for advanced wound care products. As the population ages and chronic diseases become more prevalent, there is a growing need for innovative wound care solutions that promote faster healing and reduce the risk of complications. This has led to a rise in the adoption of products such as wound dressings, wound closure devices, and negative pressure wound therapy systems. Another trend in the market is the growing focus on infection control. Healthcare-associated infections are a major concern in the United States, and wound care products that help prevent infection are in high demand. Antimicrobial dressings and wound cleansers that can effectively kill bacteria and prevent the spread of infection are gaining popularity among both healthcare professionals and consumers.

Local special circumstances: The United States has a well-developed healthcare system with a strong network of pharmacies. This makes it easy for consumers to access wound care products without the need for a prescription. Additionally, the presence of major pharmacy chains and online pharmacies provides customers with a wide range of options and competitive pricing.

Underlying macroeconomic factors: The United States has a large and aging population, which contributes to the growth of the Wound Care (Pharmacies) market. As the population ages, the incidence of chronic wounds and conditions such as diabetes and obesity increases, driving the demand for wound care products. Furthermore, the United States has a high healthcare expenditure per capita, indicating a willingness to invest in healthcare products and services. This, coupled with the increasing prevalence of chronic diseases, creates a favorable market environment for the growth of the Wound Care (Pharmacies) market. In conclusion, the Wound Care (Pharmacies) market in United States is witnessing growth due to customer preferences for convenience and accessibility, the increasing demand for advanced wound care products, the focus on infection control, the well-developed healthcare system with a strong network of pharmacies, and the underlying macroeconomic factors such as the aging population and high healthcare expenditure.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.